slides · global inventory
Comparison Frame
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,294
Current window 4,261-4,290
Pages 210
Rows per page 30
Framework
4,261-4,290 of 6,294
12
The slide uses a table to show symptom overlap (+) and absence (-) between two conditions, accompanied by a visual comparison of patients.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
Forest plot showing safety outcomes; includes p-value for overall effect.Aldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations 1 hit
08
The slide uses a checkmark/cross matrix to highlight AITi's unique positioning across both wealth and asset management segments.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Logic Chain1 hit
07
The table highlights ApolloMed's unique combination of scale, patient coverage, and profitability compared to peers.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
09
The slide uses a comparison frame to justify the market transition.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Problem1 hit
24
The chart uses a grouped bar chart format to compare performance metrics across five categories.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
15
Includes chemical structure diagrams and multiple bar charts showing dose-response relationships.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
18
The slide uses a matrix-style comparison table to highlight competitive advantages.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
13
The slide uses a third-party study (Yang et al., 2015) to support the claim of a superior therapeutic index for R-ketamine.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
The slide uses a simple additive equation visual to represent the growth of the company's CNS portfolio.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
10
The table uses checkmarks to indicate the strength of effect for different GABA-A subtypes (alpha 1, 2, 3, 5).Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution1 hit
20
The slide uses a comparison table to frame BAER-101's selectivity profile as a competitive advantage.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
08
The slide uses a comparative framework to contrast industry standards with AI-enhanced outcomes across two distinct R&D phases.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a comparison framework to highlight efficiency gains in drug discovery.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
11
The chart segments companies by the number of commercialized products and compares their IND filing rates (2015-2020) against BenevolentAI's projected targets.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
46
The slide uses a comparison table to contrast the drug's mechanism of action against competitors and highlights safety concerns with current standards of care.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
44
The table uses checkmarks and X marks to denote presence or absence of specific clinical benefits/side effects.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
05
The slide uses a comparative structure to explain two different CAR-T approaches.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a comparison table structure to differentiate between Mucosal PV and Mucocutaneous PV, followed by a list of clinical limitations of current standard-of-care treatments.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a consistent color scheme to compare the subject company against a peer group of public banks with $3-10 billion in assets.Central Pacific Financial | Results Presentation Deck | 12 slides · Central Pacific Financial
Conference presentation Investor relations Beat · EvidenceLoop · Zoom In1 hit
05
Uses a comparative framework to validate market potential by citing peak sales of existing products.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Beat · Market Size1 hit
18
The slide uses a two-part comparison structure to highlight operational advantages.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
38
The slide uses a comparative structure to show evolution from the Kuwait pilot to the Singapore next-gen facility.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
05
The slide uses a visual comparison of vehicle silhouettes to anchor three distinct bar charts representing different performance metrics.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations 1 hit
05
The slide uses a visual comparison framework to position TRuC-T cells as a superior technological evolution.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
06
The slide uses a 2x2 layout to present four distinct experimental results supporting the superiority of TRuC technology.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
07
The slide uses a comparative structure to frame gavo-cel as a superior therapeutic option compared to historical anti-mesothelin CAR-T approaches.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
21
The chart uses a grouped bar structure to compare two categories (VMC States vs Other States) across four time periods.Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · Evidence1 hit
43
VMC (Vulcan Materials Company) vs. Peer average (MLM, SUM, EXP, CRH, CX).Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · Development1 hit
62
The slide uses a simple comparison frame to highlight operational efficiency against macroeconomic trends.Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · Resolution1 hit